If you look at the price tag attached to the exclu

If you look at the price tag attached to the exclusive rights to this particular patent, one has to conclude that there are many things a brewin' that spell out beaucoup $$$ for the company within the next 12 months. Koos cannot default on this. I mean,he could but he wont.

I hate to speculate, but all my reading and chit-chats tell me that a not-so little European BP has a keen interest in this particular leg of the research.

There might be a bit more dilution, but a R/S would kill the company and any credibility Koos has established. Seriously, look at the price tag...the negotiations for this were not just pulled out of thin air with a promise to deliver--Koos has something up his sleeve.

BTW, has anyone seen the flip-flop of our favorite poster? Where are those bi-polar meds???